| Financial Year |
March 31 2023 |
| Monetary Funds |
2,840,556,347.95 |
| Held-for-trading Financial Assets |
31,890,661.56 |
| Notes Receivable |
102,869,448.95 |
| Accounts Receivable |
2,754,010,775.00 |
| Advances to Suppliers |
6,934,207.85 |
| Other Receivables |
111,322,927.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,265,570,476.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,324,518.06 |
| Total Current Assets |
11,064,028,543.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
445,964,556.37 |
| Investment Properties |
80,845,527.87 |
| Fixed Assetes |
953,110,697.59 |
| Under-construction Projects |
115,007,520.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,533,149.20 |
| R&D expenses |
28,342,421.74 |
| Goodwill |
49,422,128.36 |
| Long-Term Deferred and Prepaid Expenses |
125,338,842.44 |
| Deferred Income Tax Assets |
162,144,236.31 |
| Other Non-Current Assets |
19,885,010.77 |
| Sub-Total of Non-Current Assets |
3,692,135,761.97 |
| Total Assets |
14,756,164,305.91 |
| Short-Term Loans |
186,299,802.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
56,609,308.06 |
| Accounts Payable |
5,464,834,974.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
305,999,907.32 |
| Taxes Payable |
214,752,926.09 |
| Interest Payable |
-- |
| Dividend Payable |
25,528,636.78 |
| Other payables |
495,291,607.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
124,905,698.11 |
| Other Current Liabilities |
91,262,753.43 |
| Sub-Total of Current Liabilities |
8,619,850,749.43 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
553,092.45 |
| Deferred Income Tax Liabilities |
25,719,867.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,141,511,295.90 |
| Total Liabilities |
9,761,362,045.33 |
| Paid-In Capital(Or Share Stock) |
178,823,529.00 |
| Capital Surplus |
2,353,859,537.24 |
| Surplus Reserve |
88,461,630.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,998,781,938.14 |
| Minority Stockholder's Interest |
376,288,365.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,618,513,894.94 |
| Owner's Equity（Stockholder's Equity） |
4,994,802,260.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,756,164,305.91 |
